New Targeted Therapies in Breast Cancer

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This study focuses on key endocrine pathways involved in the remodelling of the breast stromal cells into a reactive stromal environment which is more permissive for tumour growth. We have identified key pathways involved in the regulation of estrogen biosynthesis and fibrosis in tumour associated stroma. These studies will lead to the development of novel breast cancer therapies.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Career Development Fellowships

Funding Amount: $421,747.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Cell Biology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

angiotensin receptor | breast cancer | breast cancer prevention | drug discovery | endocrinology